ACHV
Achieve Life SciencesDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
ACHV vs peer average
53/100
ACHV vs. peer average (D vs. D)
Grade spread
C 3 · D 2 · F 5
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
DRUG is the first available peer comparator.
Bright Minds Biosciences is mainly a small-cap development-stage biotech size/stage comp rather than a direct nicotine-dependence peer; useful for financing and binary-risk framing, but not for indication-specific commercialization comps.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ACHV
Achieve Life Sciences
DRUG
Bright Minds Biosciences
Grade
D
F
Momentum
61
13
Value
41
41
Sentiment
42
41
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs DRUG
ACHV / DRUG
Grade Position
In line
ACHV vs. peer average (D vs. D)
53/100
Momentum
61
ACHVValue
41
ACHVSentiment
42
ACHVRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ACHV
DRUG is the first peer returned for this comparison set.